HSIC
Henry Schein, Inc.
Price Chart
Latest Quote
$82.82
+2.72 (+3.40%)
Current Price
| Previous Close | $80.10 |
| Open | $81.00 |
| Day High | $83.15 |
| Day Low | $80.55 |
| Volume | 1,062,922 |
Stock Information
| Shares Outstanding | 113.92M |
| Total Debt | $3.75B |
| Cash Equivalents | $138.00M |
| Revenue | $13.38B |
| Net Income | $395.00M |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | $9.43B |
| P/E Ratio | 25.02 |
| EPS (TTM) | $3.31 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $14.61B |
| Sales | $13.38B |
| Income | $395.00M |
| Book/sh | $28.54 |
| Cash/sh | $1.21 |
| Employees | 25K |
Financial Ratios
| Quick Ratio | 0.56 |
| Current Ratio | 1.36 |
| Debt/Eq | 77.75 |
| EPS Growth TTM | -2.70% |
Returns & Margins
| ROA | 4.35% |
| ROE | 8.76% |
| Gross Margin | 31.19% |
| Operating Margin | 5.85% |
| Profit Margin | 2.95% |
Ownership
| Insider Ownership | 0.82% |
| Institutional Ownership | 108.25% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 14.00 |
| PEG | 1.73 |
| P/S | 0.70 |
| P/B | 2.90 |
Analyst Data
| Recommendation | buy |
| Target Price | $88.07 |
Technical Indicators
| SMA20 | $78.63 |
| SMA50 | $76.09 |
| SMA200 | $73.85 |
| RSI | 73.85 |
| ATR | 1.9743 |
| Shares Float | 93.88M |
| Short Float | 8.63% |
| Short Ratio | 4.46 |
| Volatility | 0.82 |
| Rel Volume | 0.76 |
Performance History
| Week | +1.98% |
| Month | +11.60% |
| Quarter | +11.89% |
| 6 Months | +7.07% |
| YTD | +7.81% |
| Year | +15.20% |
| 3 Years | +6.15% |
| 5 Years | +6.97% |
| 10 Years | +25.90% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $82.82 | 1,062,922 |
| 2026-06-23 | $80.10 | 1,368,000 |
| 2026-06-22 | $78.67 | 1,029,100 |
| 2026-06-18 | $79.92 | 2,084,100 |
| 2026-06-17 | $79.97 | 954,900 |
| 2026-06-16 | $81.21 | 791,900 |
| 2026-06-15 | $81.09 | 1,185,100 |
| 2026-06-12 | $81.25 | 1,122,200 |
| 2026-06-11 | $80.22 | 1,704,100 |
| 2026-06-10 | $78.85 | 1,445,200 |
| 2026-06-09 | $80.03 | 2,259,300 |
| 2026-06-08 | $78.05 | 1,177,700 |
| 2026-06-05 | $77.45 | 1,285,200 |
| 2026-06-04 | $76.30 | 1,359,800 |
| 2026-06-03 | $75.74 | 1,156,100 |
| 2026-06-02 | $76.04 | 1,492,800 |
| 2026-06-01 | $76.40 | 1,356,100 |
| 2026-05-29 | $76.58 | 2,454,500 |
| 2026-05-28 | $76.32 | 989,700 |
| 2026-05-27 | $75.67 | 1,860,200 |
| 2026-05-26 | $73.90 | 1,228,500 |
About Henry Schein, Inc.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
đ° Latest News
Is Henry Schein Stock Underperforming the Nasdaq?
Barchart âĸ 2026-06-23T14:31:49Z
3 Unpopular Stocks We Approach with Caution
StockStory âĸ 2026-06-18T14:37:28Z
How Investors Are Reacting To Henry Schein (HSIC) Upgrade On Dental Strength And Margin Improvements
Simply Wall St. âĸ 2026-06-14T11:06:40Z
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
The Fly âĸ 2026-06-11T13:38:31Z
Here Are Thursdayâs Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More
24/7 Wall St. âĸ 2026-06-11T12:04:30Z
M.D. Sass Exits Sallie Mae -- Selling Its Entire $33.1 Million Stake
Motley Fool âĸ 2026-06-09T11:16:54Z
Why Is Henry Schein (HSIC) Up 4.6% Since Last Earnings Report?
Zacks âĸ 2026-06-04T15:30:16Z
Henry Schein Sees Steady Dental Demand, $125M Profit Lift by 2026
MarketBeat âĸ 2026-05-30T08:02:19Z
3 Healthcare Stocks We Approach with Caution
StockStory âĸ 2026-05-29T17:28:38Z
Is This the Right Time to Keep HSIC Stock in Your Portfolio?
Zacks âĸ 2026-05-28T13:26:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $9,061,000,000 | $8,640,000,000 | $8,466,000,000 | $8,804,000,000 |
| Cost Of Revenue | $9,079,000,000 | $8,657,000,000 | $8,479,000,000 | $8,816,000,000 |
| Total Revenue | $13,184,000,000 | $12,673,000,000 | $12,339,000,000 | $12,647,000,000 |
| Operating Revenue | $13,184,000,000 | $12,673,000,000 | $12,339,000,000 | $12,647,000,000 |
| Expenses | ||||
| Interest Expense | $150,000,000 | $131,000,000 | $87,000,000 | $35,000,000 |
| Total Expenses | $12,426,000,000 | $11,942,000,000 | $11,644,000,000 | $11,769,000,000 |
| Other Income Expense | $-108,000,000 | $-111,000,000 | $-83,000,000 | $-130,000,000 |
| Other Non Operating Income Expenses | $-3,000,000 | $-1,000,000 | $-3,000,000 | $1,000,000 |
| Net Non Operating Interest Income Expense | $-117,000,000 | $-107,000,000 | $-70,000,000 | $-27,000,000 |
| Interest Expense Non Operating | $150,000,000 | $131,000,000 | $87,000,000 | $35,000,000 |
| Operating Expense | $3,347,000,000 | $3,285,000,000 | $3,165,000,000 | $2,953,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $398,000,000 | $390,000,000 | $416,000,000 | $538,000,000 |
| Net Interest Income | $-117,000,000 | $-107,000,000 | $-70,000,000 | $-27,000,000 |
| Interest Income | $33,000,000 | $24,000,000 | $17,000,000 | $8,000,000 |
| Normalized Income | $478,115,000 | $472,610,000 | $478,287,823 | $638,215,000 |
| Net Income From Continuing And Discontinued Operation | $398,000,000 | $390,000,000 | $416,000,000 | $538,000,000 |
| Total Operating Income As Reported | $653,000,000 | $621,000,000 | $615,000,000 | $747,000,000 |
| Net Income Common Stockholders | $398,000,000 | $390,000,000 | $416,000,000 | $538,000,000 |
| Net Income | $398,000,000 | $390,000,000 | $416,000,000 | $538,000,000 |
| Net Income Including Noncontrolling Interests | $419,000,000 | $398,000,000 | $436,000,000 | $566,000,000 |
| Net Income Continuous Operations | $419,000,000 | $398,000,000 | $436,000,000 | $566,000,000 |
| Earnings From Equity Interest Net Of Tax | $12,000,000 | $13,000,000 | $14,000,000 | $15,000,000 |
| Pretax Income | $533,000,000 | $513,000,000 | $542,000,000 | $721,000,000 |
| Special Income Charges | $-105,000,000 | $-110,000,000 | $-80,000,000 | $-131,000,000 |
| Interest Income Non Operating | $33,000,000 | $24,000,000 | $17,000,000 | $8,000,000 |
| Operating Income | $758,000,000 | $731,000,000 | $695,000,000 | $878,000,000 |
| Depreciation Amortization Depletion Income Statement | $263,000,000 | $251,000,000 | $209,000,000 | $182,000,000 |
| Depreciation And Amortization In Income Statement | $263,000,000 | $251,000,000 | $209,000,000 | $182,000,000 |
| Gross Profit | $4,105,000,000 | $4,016,000,000 | $3,860,000,000 | $3,831,000,000 |
| Net Income Discontinuous Operations | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $3.27 | $3.05 | $3.16 | $3.91 |
| Basic EPS | $3.29 | $3.07 | $3.18 | $3.95 |
| Other | ||||
| Tax Effect Of Unusual Items | $-24,885,000 | $-27,390,000 | $-17,712,177 | $-30,785,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,069,000,000 | $1,022,000,000 | $931,000,000 | $1,081,000,000 |
| Total Unusual Items | $-105,000,000 | $-110,000,000 | $-80,000,000 | $-131,000,000 |
| Total Unusual Items Excluding Goodwill | $-105,000,000 | $-110,000,000 | $-80,000,000 | $-131,000,000 |
| Reconciled Depreciation | $281,000,000 | $268,000,000 | $222,000,000 | $194,000,000 |
| EBITDA (Bullshit earnings) | $964,000,000 | $912,000,000 | $851,000,000 | $950,000,000 |
| EBIT | $683,000,000 | $644,000,000 | $629,000,000 | $756,000,000 |
| Diluted Average Shares | $121,717,876 | $127,779,228 | $131,748,171 | $137,755,670 |
| Basic Average Shares | $120,813,977 | $126,788,997 | $130,618,990 | $136,064,221 |
| Diluted NI Availto Com Stockholders | $398,000,000 | $390,000,000 | $416,000,000 | $538,000,000 |
| Minority Interests | $-21,000,000 | $-8,000,000 | $-20,000,000 | $-28,000,000 |
| Tax Provision | $126,000,000 | $128,000,000 | $120,000,000 | $170,000,000 |
| Restructuring And Mergern Acquisition | $105,000,000 | $110,000,000 | $80,000,000 | $131,000,000 |
| Selling General And Administration | $3,084,000,000 | $3,034,000,000 | $2,956,000,000 | $2,771,000,000 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,986,000,000 | $-1,517,000,000 | $-1,136,000,000 | $-34,000,000 |
| Total Assets | $11,215,000,000 | $10,218,000,000 | $10,573,000,000 | $8,607,000,000 |
| Total Non Current Assets | $6,751,000,000 | $6,235,000,000 | $6,085,000,000 | $4,619,000,000 |
| Other Non Current Assets | $149,000,000 | $118,000,000 | $101,000,000 | $105,000,000 |
| Non Current Prepaid Assets | $4,000,000 | $4,000,000 | $4,000,000 | $3,000,000 |
| Non Current Deferred Assets | $204,000,000 | $137,000,000 | $133,000,000 | $167,000,000 |
| Non Current Deferred Taxes Assets | $92,000,000 | $47,000,000 | $38,000,000 | $88,000,000 |
| Non Current Note Receivables | $56,000,000 | $63,000,000 | $44,000,000 | $28,000,000 |
| Goodwill And Other Intangible Assets | $5,231,000,000 | $4,910,000,000 | $4,791,000,000 | $3,480,000,000 |
| Other Intangible Assets | $1,018,000,000 | $1,023,000,000 | $916,000,000 | $587,000,000 |
| Current Assets | $4,464,000,000 | $3,983,000,000 | $4,488,000,000 | $3,988,000,000 |
| Other Current Assets | $655,000,000 | $569,000,000 | $639,000,000 | $466,000,000 |
| Inventory | $2,002,000,000 | $1,810,000,000 | $1,815,000,000 | $1,963,000,000 |
| Receivables | $1,651,000,000 | $1,482,000,000 | $1,863,000,000 | $1,442,000,000 |
| Accounts Receivable | $1,651,000,000 | $1,482,000,000 | $1,863,000,000 | $1,442,000,000 |
| Allowance For Doubtful Accounts Receivable | $-90,000,000 | $-78,000,000 | $-83,000,000 | $-65,000,000 |
| Gross Accounts Receivable | $1,741,000,000 | $1,560,000,000 | $1,946,000,000 | $1,507,000,000 |
| Cash Cash Equivalents And Short Term Investments | $156,000,000 | $122,000,000 | $171,000,000 | $117,000,000 |
| Cash And Cash Equivalents | $156,000,000 | $122,000,000 | $171,000,000 | $117,000,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $2,951,000,000 | $2,414,000,000 | $2,180,000,000 | $1,032,000,000 |
| Total Debt | $3,436,000,000 | $2,870,000,000 | $2,741,000,000 | $1,497,000,000 |
| Long Term Debt And Capital Lease Obligation | $2,561,000,000 | $2,089,000,000 | $2,247,000,000 | $1,315,000,000 |
| Long Term Debt | $2,310,000,000 | $1,830,000,000 | $1,937,000,000 | $1,040,000,000 |
| Current Debt And Capital Lease Obligation | $875,000,000 | $781,000,000 | $494,000,000 | $182,000,000 |
| Current Debt | $797,000,000 | $706,000,000 | $414,000,000 | $109,000,000 |
| Other Current Borrowings | $33,000,000 | $56,000,000 | $150,000,000 | $6,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $6,421,000,000 | $5,381,000,000 | $5,420,000,000 | $3,936,000,000 |
| Total Non Current Liabilities Net Minority Interest | $3,193,000,000 | $2,578,000,000 | $2,737,000,000 | $1,712,000,000 |
| Other Non Current Liabilities | $486,000,000 | $387,000,000 | $436,000,000 | $361,000,000 |
| Non Current Deferred Liabilities | $146,000,000 | $102,000,000 | $54,000,000 | $36,000,000 |
| Non Current Deferred Taxes Liabilities | $146,000,000 | $102,000,000 | $54,000,000 | $36,000,000 |
| Current Liabilities | $3,228,000,000 | $2,803,000,000 | $2,683,000,000 | $2,224,000,000 |
| Payables And Accrued Expenses | $2,353,000,000 | $2,022,000,000 | $2,189,000,000 | $2,042,000,000 |
| Payables | $1,333,000,000 | $1,101,000,000 | $1,157,000,000 | $1,136,000,000 |
| Total Tax Payable | $179,000,000 | $139,000,000 | $137,000,000 | $132,000,000 |
| Accounts Payable | $1,154,000,000 | $962,000,000 | $1,020,000,000 | $1,004,000,000 |
| Equity | ||||
| Common Stock Equity | $3,245,000,000 | $3,393,000,000 | $3,655,000,000 | $3,446,000,000 |
| Total Equity Gross Minority Interest | $4,794,000,000 | $4,837,000,000 | $5,153,000,000 | $4,671,000,000 |
| Stockholders Equity | $3,245,000,000 | $3,393,000,000 | $3,655,000,000 | $3,446,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-226,000,000 | $-379,000,000 | $-206,000,000 | $-233,000,000 |
| Other Equity Adjustments | $-226,000,000 | $-379,000,000 | $-206,000,000 | $-233,000,000 |
| Retained Earnings | $3,293,000,000 | $3,771,000,000 | $3,860,000,000 | $3,678,000,000 |
| Long Term Equity Investment | $174,000,000 | $170,000,000 | $180,000,000 | $161,000,000 |
| Preferred Securities Outside Stock Equity | - | - | - | $576,000,000 |
| Other | ||||
| Ordinary Shares Number | $115,771,149 | $124,155,884 | $129,247,765 | $131,792,817 |
| Share Issued | $115,771,149 | $124,155,884 | $129,247,765 | $131,792,817 |
| Tangible Book Value | $-1,986,000,000 | $-1,517,000,000 | $-1,136,000,000 | $-34,000,000 |
| Invested Capital | $6,352,000,000 | $5,929,000,000 | $6,006,000,000 | $4,595,000,000 |
| Working Capital | $1,236,000,000 | $1,180,000,000 | $1,805,000,000 | $1,764,000,000 |
| Capital Lease Obligations | $329,000,000 | $334,000,000 | $390,000,000 | $348,000,000 |
| Total Capitalization | $5,555,000,000 | $5,223,000,000 | $5,592,000,000 | $4,486,000,000 |
| Minority Interest | $1,549,000,000 | $1,444,000,000 | $1,498,000,000 | $1,225,000,000 |
| Additional Paid In Capital | $177,000,000 | $0 | $0 | $0 |
| Capital Stock | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 |
| Common Stock | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $251,000,000 | $259,000,000 | $310,000,000 | $275,000,000 |
| Current Capital Lease Obligation | $78,000,000 | $75,000,000 | $80,000,000 | $73,000,000 |
| Line Of Credit | $764,000,000 | $650,000,000 | $264,000,000 | $103,000,000 |
| Current Accrued Expenses | $1,020,000,000 | $921,000,000 | $1,032,000,000 | $906,000,000 |
| Defined Pension Benefit | $11,000,000 | $9,000,000 | $9,000,000 | $8,000,000 |
| Investments And Advances | $174,000,000 | $170,000,000 | $180,000,000 | $161,000,000 |
| Goodwill | $4,213,000,000 | $3,887,000,000 | $3,875,000,000 | $2,893,000,000 |
| Net PPE | $922,000,000 | $824,000,000 | $823,000,000 | $667,000,000 |
| Accumulated Depreciation | $-759,000,000 | $-670,000,000 | $-672,000,000 | $-573,000,000 |
| Gross PPE | $1,681,000,000 | $1,494,000,000 | $1,495,000,000 | $1,240,000,000 |
| Leases | $125,000,000 | $109,000,000 | $103,000,000 | $94,000,000 |
| Other Properties | $301,000,000 | $293,000,000 | $325,000,000 | $284,000,000 |
| Machinery Furniture Equipment | $1,046,000,000 | $908,000,000 | $880,000,000 | $707,000,000 |
| Buildings And Improvements | $187,000,000 | $164,000,000 | $166,000,000 | $135,000,000 |
| Land And Improvements | $22,000,000 | $20,000,000 | $21,000,000 | $20,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Treasury Shares Number | - | - | $0 | - |
| Investmentsin Associatesat Cost | - | - | - | $161,000,000 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $521,000,000 | $661,000,000 | $313,000,000 | $474,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $712,000,000 | $848,000,000 | $500,000,000 | $602,000,000 |
| Cash Flow From Continuing Operating Activities | $712,000,000 | $848,000,000 | $500,000,000 | $602,000,000 |
| Operating Gains Losses | $-12,000,000 | $-13,000,000 | $-14,000,000 | $-15,000,000 |
| Cash From Discontinued Operating Activities | - | - | - | $0 |
| Investing Activities | ||||
| Capital Expenditure | $-191,000,000 | $-187,000,000 | $-187,000,000 | $-128,000,000 |
| Investing Cash Flow | $-400,000,000 | $-430,000,000 | $-1,135,000,000 | $-276,000,000 |
| Cash Flow From Continuing Investing Activities | $-400,000,000 | $-430,000,000 | $-1,135,000,000 | $-276,000,000 |
| Net Other Investing Changes | $-10,000,000 | $-13,000,000 | $-15,000,000 | $10,000,000 |
| Capital Expenditure Reported | $-52,000,000 | $-39,000,000 | $-40,000,000 | $-32,000,000 |
| Cash From Discontinued Investing Activities | - | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-850,000,000 | $-385,000,000 | $-250,000,000 | $-485,000,000 |
| Issuance Of Capital Stock | $250,000,000 | $0 | $0 | - |
| Financing Cash Flow | $-188,000,000 | $-510,000,000 | $701,000,000 | $-315,000,000 |
| Cash Flow From Continuing Financing Activities | $-188,000,000 | $-510,000,000 | $701,000,000 | $-315,000,000 |
| Net Other Financing Charges | $-143,000,000 | $-320,000,000 | $-103,000,000 | $-91,000,000 |
| Net Common Stock Issuance | $-600,000,000 | $-385,000,000 | $-250,000,000 | $-485,000,000 |
| Common Stock Issuance | $250,000,000 | $0 | $0 | - |
| Dividend Received Cfo | $11,000,000 | $12,000,000 | $15,000,000 | $15,000,000 |
| Cash From Discontinued Financing Activities | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-44,000,000 | $-318,000,000 | $-468,000,000 | $-59,000,000 |
| Issuance Of Debt | $489,000,000 | $120,000,000 | $1,368,000,000 | $270,000,000 |
| Interest Paid Supplemental Data | $151,000,000 | $132,000,000 | $84,000,000 | $47,000,000 |
| End Cash Position | $156,000,000 | $122,000,000 | $171,000,000 | $117,000,000 |
| Beginning Cash Position | $122,000,000 | $171,000,000 | $117,000,000 | $118,000,000 |
| Effect Of Exchange Rate Changes | $-90,000,000 | $43,000,000 | $-12,000,000 | $-12,000,000 |
| Changes In Cash | $124,000,000 | $-92,000,000 | $66,000,000 | $11,000,000 |
| Proceeds From Stock Option Exercised | $2,000,000 | $6,000,000 | $1,000,000 | $2,000,000 |
| Common Stock Payments | $-850,000,000 | $-385,000,000 | $-250,000,000 | $-485,000,000 |
| Net Issuance Payments Of Debt | $553,000,000 | $189,000,000 | $1,053,000,000 | $259,000,000 |
| Net Short Term Debt Issuance | $108,000,000 | $387,000,000 | $153,000,000 | $48,000,000 |
| Net Long Term Debt Issuance | $445,000,000 | $-198,000,000 | $900,000,000 | $211,000,000 |
| Long Term Debt Payments | $-44,000,000 | $-318,000,000 | $-468,000,000 | $-59,000,000 |
| Long Term Debt Issuance | $489,000,000 | $120,000,000 | $1,368,000,000 | $270,000,000 |
| Net Investment Purchase And Sale | $0 | $0 | $22,000,000 | $0 |
| Sale Of Investment | $0 | $0 | $22,000,000 | $0 |
| Net Business Purchase And Sale | $-199,000,000 | $-230,000,000 | $-955,000,000 | $-158,000,000 |
| Purchase Of Business | $-199,000,000 | $-230,000,000 | $-955,000,000 | $-158,000,000 |
| Net PPE Purchase And Sale | $-139,000,000 | $-148,000,000 | $-147,000,000 | $-96,000,000 |
| Purchase Of PPE | $-139,000,000 | $-148,000,000 | $-147,000,000 | $-96,000,000 |
| Change In Working Capital | $-48,000,000 | $140,000,000 | $-290,000,000 | $-281,000,000 |
| Change In Other Current Assets | $-45,000,000 | $47,000,000 | $-138,000,000 | $-52,000,000 |
| Change In Payables And Accrued Expense | $216,000,000 | $-163,000,000 | $-56,000,000 | $-96,000,000 |
| Change In Inventory | $-95,000,000 | $-59,000,000 | $231,000,000 | $-126,000,000 |
| Change In Receivables | $-124,000,000 | $315,000,000 | $-327,000,000 | $-7,000,000 |
| Changes In Account Receivables | $-124,000,000 | $315,000,000 | $-327,000,000 | $-7,000,000 |
| Other Non Cash Items | $-49,000,000 | $5,000,000 | $24,000,000 | $73,000,000 |
| Stock Based Compensation | $39,000,000 | $39,000,000 | $39,000,000 | $54,000,000 |
| Provisionand Write Offof Assets | $16,000,000 | $14,000,000 | $18,000,000 | $5,000,000 |
| Asset Impairment Charge | $16,000,000 | $12,000,000 | $34,000,000 | $34,000,000 |
| Amortization Of Securities | $30,000,000 | $29,000,000 | $26,000,000 | $18,000,000 |
| Deferred Tax | $9,000,000 | $-56,000,000 | $-10,000,000 | $-61,000,000 |
| Deferred Income Tax | $9,000,000 | $-56,000,000 | $-10,000,000 | $-61,000,000 |
| Depreciation Amortization Depletion | $281,000,000 | $268,000,000 | $222,000,000 | $194,000,000 |
| Depreciation And Amortization | $281,000,000 | $268,000,000 | $222,000,000 | $194,000,000 |
| Amortization Cash Flow | $180,000,000 | $185,000,000 | $152,000,000 | $126,000,000 |
| Amortization Of Intangibles | $180,000,000 | $185,000,000 | $152,000,000 | $126,000,000 |
| Depreciation | $101,000,000 | $83,000,000 | $70,000,000 | $68,000,000 |
| Earnings Losses From Equity Investments | $-12,000,000 | $-13,000,000 | $-14,000,000 | $-15,000,000 |
| Net Income From Continuing Operations | $419,000,000 | $398,000,000 | $436,000,000 | $566,000,000 |
| Income Tax Paid Supplemental Data | - | $144,000,000 | $218,000,000 | $265,000,000 |
| Sale Of Business | - | - | $0 | $0 |
| Gain Loss On Sale Of Business | - | - | - | $0 |
Fetched: 2026-06-20